$RGBP Regen BioPharma, Inc. Addresses Potential Impact of Recent Bristol Myers Squibb $2.3 Billion Acquisition of IFM Therapeutics http://www.frontpagestocks.com/regen-biopharma-inc-rgbp/ @frontpagestocks